Overview of HIV Among Injection Drug Users in New York City: Critical Next Steps to Eliminate Racial/Ethnic Disparities

REFERENCES

• Absalon, J., Fuller, C. M., Ompad, D. C., Blaney, S., Koblin, B., Galea, S., (2006). Gender differences in sexual behaviors, sexual partnerships and HIV among drug users in New York City. AIDS & Behavior, 10, 707–715.
   PubMed Web of Science ®Google Scholar
• Andersen, R., Bozzette, S., Shapiro, M., Clair, P. St., Morton, S., Crystal, S., (2000). Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS consortium. HIV cost and services utilization study. Health Services Research, 35, 389–416.
   PubMed Web of Science ®Google Scholar
• Andrulis, D. P., Weslowski, V. B., Hintz, E., & Spolarich, A. W. (1992). Comparisons of hospital care for patients with AIDS and other HIV-related conditions. Journal of the American Medical Association, 267, 2482–2486.
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R. N., Kral, A. H., Erringer, E. A., & Edlin, B. R. (1998). Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 18(5), 505–511.
   PubMedGoogle Scholar
• Bluthenthal, R. N., Kral, A. H., Lorvick, J., & Warters, J. K. (1997). Impact of law enforcement on syringe exchange programs: A look at Oakland and San Francisco. Medical Anthropology, 18, 61–83.
   PubMedGoogle Scholar
• Broz, D., & Ouellet, L. J. (2008). Racial and ethnic changes in heroin injection in the United States: Implications for the HIV/AIDS epidemic. Drug and Alcohol Dependence, 94, 221–233.
   PubMed Web of Science ®Google Scholar
• Celentano, D. D., Munoz, A., Cohn, S., & Vlahov, D. (2001). Dynamics of behavioral risk factors for HIV/AIDS: A 6-year prospective study of injection drug users. Drug and Alcohol Dependence, 61, 315–322.
   PubMed Web of Science ®Google Scholar
• Celentano, D. D., Vlahov, D., Cohn, S., Shadle, V. M., Obasanjo, O., & Moore, R. D. (1998). Self-reported antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 544–546.
   PubMed Web of Science ®Google Scholar
• Center for Urban Epidemiologic Studies. (2003). New York State expanded syringe access demonstration program evaluation: Evaluation report to the Governor and the New York State legislation. New York, NY: Center for Urban Epidemiologic Studies, New York Academy of Medicine.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2002). Drug-associated HIV transmission continues in the United States. Atlanta, GA: Center for Disease Control and Prevention, Department of Health and Human Services.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2007). HIV/AIDS surveillance report. Volume 19. Atlanta, GA: Center for Disease Control and Prevention, Department of Health and Human Services.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2006). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Morbidity and Mortality Weekly Report, 55(14), 1–17.
   PubMedGoogle Scholar
• Colon, H. M., Robles, R. R., Freeman, D., & Matos, T. (1993). Effects of a HIV risk reduction education program among injection drug users in Puerto Rico. Puerto Rico Health Sciences Journal, 12, 27–34.
   PubMedGoogle Scholar
• Cooper, H. L., Bossak, B., Tempalski, B., Des Jarlais, D. C., & Friedman, S. R. (2009a). Geographic approaches to quantifying the risk environment: Drug-related law enforcement and access to syringe exchange programmes. International Journal of Drug Policy, 20(3), 217–226.
   PubMed Web of Science ®Google Scholar
• Cotten-Oldenburg, N. U., Carr, P., DeBoer, J. M., Collison, E. K., & Novotny, G. (2001). Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. Journal of Acquired Immune Deficiency Syndrome, 27, 183–192.
   PubMed Web of Science ®Google Scholar
• Cronquist, A., Edwards, V., Galea, S., Latka, M., & Vlahov, D. (2001). Health care utilization among young adult injection drug users in Harlem, New York. Journal of Substance Abuse, 13, 17–27.
   PubMedGoogle Scholar
• Delgado, M., Lundgren, L. M., Deshpande, A., Lonsdale, J., & Purington, T. (2008). The association between acculturation and needle sharing among Puerto Rican injection drug users. Evaluation and Program Planning, 31, 83–91.
   PubMed Web of Science ®Google Scholar
• Deren, S., Kang, S. Y., Colón, H. M., Andia, J. F., Robles, R. R., Oliver-Velez, D., (2003). Migration and HIV risk behaviors: Puerto Rican drug injectors in New York City and Puerto Rico. American Journal of Public Health, 93(5), 812–816.
   PubMed Web of Science ®Google Scholar
• Deren, S., Kang, S. Y., Colón, H. M., & Robles, R. R. (2007). The Puerto Rico–New York airbridge for drug users: Description and relationship to HIV risk behaviors. Journal of Urban Health, 84(2), 243–254.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Arasteh, K., Hagan, H., McKnight, C., Perlman, D., & Friedman, S. (2009). Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. American Journal of Public Health, 99(Suppl. 2), S445–S451.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Marmor, M., Friedmann, P., Titus, S., Aviles, E., Deren, S., (2000). HIV incidence among injection drug users in New York City, 1992–1997: Evidence for a declining epidemic. American Journal of Public Health, 90(3), 352–359.
   Google Scholar
• Des Jarlais, D. C., Marmor, M., Paone, D., Titus, S., Shi, Q., Perlis, T., (1996). HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet, 348, 987–991.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Perlis, T., Arasteh, K., Hagan, H., Milliken, J., Braine, N., (2004). “Informed altruism” and “partner restriction” in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2001. Journal of Acquired Immune Deficiency Syndrome, 35(2), 158–166.
   PubMed Web of Science ®Google Scholar
• Diaz, T., Vlahov, D., Greenberg, B., Cuevas, Y., & Garfein, R. (2001). Sexual orientation and HIV infection prevalence among young Latino injection drug users in Harlem. Journal of Women's Health and Gender-based Medicine, 10(4), 371–380.
   PubMedGoogle Scholar
• Dushay, R. A., Singer, M., Weeks, M. R., Rohena, L., & Gruber, R. (2001). Lowering HIV risk among ethnic minority drug users: Comparing culturally targeted intervention to a standard intervention. American Journal of Drug and Alcohol Abuse, 27, 501–524.
   PubMed Web of Science ®Google Scholar
• Ellickson, P. L., & Morton, S. C. (1999). Identifying adolescents at risk for hard drug use: Racial/ethnic variations. Journal of Adolescent Health, 25(6), 382–395.
   PubMed Web of Science ®Google Scholar
• Estrada, A. L. (2005). Health disparities among African-American and Hispanic drug injectors—HIV, AIDS, hepatitis B virus and hepatitis C virus: A review. AIDS, 19(Suppl. 3), S47–S52.
   PubMed Web of Science ®Google Scholar
• Freeman, R. C., Williams, M. L., & Saunders, L. A. (1999). Drug use, AIDS knowledge, and HIV risk behaviors of Cuban-, Mexican-, and Puerto-Rican-born drug injectors who are recent entrants into the United States. Substance Use and Misuse, 34(13), 1765–1793.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Cooper, H. L., & Osborne, A. H. (2009). Structural and social contexts of HIV risk among African Americans. American Journal of Public Health, 99(6), 1002–1009.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Kottiri, B. J., Neaigus, A., Curtis, R., Vermund, S. H., & Des Jarlais, D. C. (2000). Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. American Journal of Epidemiology, 152(10), 913–922.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Neaigus, A., Des Jarlais, D. C., Sotheran, J. L., Woods, J., Sufian, M., (1992). Social intervention against AIDS among injecting drug users. British Journal of Addiction, 87(3), 393–404.
   PubMedGoogle Scholar
• Friedman, S. R., Neaigus, A., Jose, B., Curtis, R., Goldstein, M., Ildefonso, G., (1997). Sociometric risk networks and risk for HIV infection. American Journal of Public Health, 87(8), 1289–1296.
   PubMed Web of Science ®Google Scholar
• Fuller, C. M., Absalon, J., Ompad, D. C., Nash, D., Koblin, B., Blaney, S., (2005). A comparison of HIV seropositive and seronegative young adult heroin- and cocaine-using men who have sex with men in New York City, 2000–2003. Journal of Urban Health, 82(1), i51–i61.
   PubMed Web of Science ®Google Scholar
• Fuller, C. M., Borrell, L. N., Latkin, C. A., Galea, S., Ompad, D. C., Strathdee, S. A., (2005). Effects of race, neighborhood, and social network on age at initiation of injection drug use. American Journal of Public Health, 95(4), 689–695.
   PubMed Web of Science ®Google Scholar
• Fuller, C. M., Galea, S., Blaney, S., Ompad, D. C., Deren, S., Des Jarlais, D., (2004). Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethnicity and Disease, 14, 589–595.
   PubMed Web of Science ®Google Scholar
• Fuller, C. M., Galea, S., Caceres, W., Blaney, S., Sisco, S., & Vlahov, D. (2007). Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. American Journal of Public Health, 97(1), 117–122.
   PubMed Web of Science ®Google Scholar
• Fuller, C. M., Vlahov, D., Arria, A. M., Ompad, D. C., Garfein, R., & Strathdee, S. A. (2001). Factors associated with adolescent initiation of injection drug use. Public Health Reports, 116(Suppl. 1), 136–145.
   PubMed Web of Science ®Google Scholar
• Fuller, C. M., Vlahov, D., Ompad, D. C., Shah, N., Arria, A., & Strathdee, S. A. (2002). High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: A case–control study. Drug and Alcohol Dependence, 66, 189–198.
   PubMed Web of Science ®Google Scholar
• Galea, S., & Vlahov, D. (2002). Social determinants and the health of drug users: Socioeconomic status, homelessness, and incarceration. Public Health Reports, 117(Suppl. 1), S135–S145.
   PubMed Web of Science ®Google Scholar
• Golub, A., & Johnson, B. D. (2001). Variation in youthful risks of progression from alcohol and tobacco to marijuana and to hard drugs across generations. American Journal of Public Health, 91, 225–232.
   PubMed Web of Science ®Google Scholar
• Groseclose, S. L., Weinstein, B., Jones, T. S., Valleroy, L. A., Fehrs, L. J., & Kassler, W. J. (1995). Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers—Connecticut, 1992–1993. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 10(1), 82–89.
   PubMedGoogle Scholar
• Harawa, N. T., Greenland, S., Bingham, T. A., Johnson, D. F., Cochran, S. D., Cunningham, W. E., (2004). Associations of race/ethnicity with HIV prevalence and HIV-related behaviors among young men who have sex with men in 7 urban centers in the United States. Journal of Acquired Immune Deficiency Syndrome, 35(5), 526–536.
   PubMed Web of Science ®Google Scholar
• Holmberg, S. D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health, 86, 642–654.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. (2006). Preventing HIV infection among injection drug users in high risk countries: An assessment of the evidence. Washington, DC: Institute of Medicine, Committee on the Prevention of HIV Infection Among Injection Drug Users in High Risk Countries.
   Google Scholar
• Kottiri, B. J., Friedman, S. R., Neaigus, A., Curtis, R., & Des Jarlais, D. (2002). Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndrome, 30, 95–104.
   PubMed Web of Science ®Google Scholar
• Kral, A. H., Lorvick, J., & Edlin, B. R. (2000). Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. Journal of Acquired Immune Deficiency Syndrome, 24, 162–167.
   PubMed Web of Science ®Google Scholar
• Latkin, C. A., Kuramoto, S. J., Davey-Rothwell, M. A., & Tobin, K. E. (2010). Social norms, social networks, and HIV risk behavior among injection drug users. AIDS and Behavior, 5, 1159–1168.
   Web of Science ®Google Scholar
• Latkin, C. A., Sherman, S., & Knowlton, A. (2003). HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention. Health Psychology, 22(4), 332–339.
   PubMed Web of Science ®Google Scholar
• MacDonald, M., & Law, M. (2003). Effectiveness of needle and syringe programmes for preventing HIV transmission. International Journal of Drug Policy, 14, 353–357.
   Google Scholar
• Mauskopf, J., Turner, B. J., Markson, L. E., Houchens, R. L., Fanning, T. R., & McKee, L. (1994). Patterns of ambulatory care for AIDS patients, and association with emergency room use. Health Services Research, 29, 489–510.
   PubMed Web of Science ®Google Scholar
• Moore, R. D., Hidalgo, J., Bareta, J. C., & Chaisson, R. E. (1994). Zidovudine therapy and health resource utilization in AIDS. Journal of Acquired Immune Deficiency Syndrome, 7, 349– 354.
   PubMed Web of Science ®Google Scholar
• National Institutes on Drug Abuse (NIDA). (2000). Principles of HIV prevention in drug-using populations. Bethesda, MD: NIDA, Department of Health and Human Development.
   Google Scholar
• Neaigus, A., Friedman, S. R., Jose, B., Goldstein, M. F., Curtis, R., Ildefonso, G., (1996). High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 11(5), 499–509.
   PubMedGoogle Scholar
• NYC HIV/AIDS Annual Surveillance Statistics. (2009). HIV epidemiology and field services program, New York City Department of Health and Mental Hygiene. Retrieved October 26, 2009, http://www.nyc.gov/html/doh/downloads/pdf/ah/surveillance2007_tables_au.pdf.
   Google Scholar
• Ompad, D. C., Fuller, C. M., Galea, S., Del Vecchio, & Vlahov, D. (2004a). HIV risk behaviors among young female drug users who have sex with women in New York City. Oral Presentation. Paper presented at the 15th International Conference on AIDS, Bangkok, Thailand.
   Google Scholar
• Ompad, D. C., Fuller, C. M., Galea, S., Wu, Y., Nash, D.,Benjamin, E., (2004b). Sexual risk is associated with HIV among injection and non-injection drug users: Implications for intervention strategies. Paper presented at the 15th International Conference on AIDS, Bangkok, Thailand.
   Google Scholar
• Rich, J. D., Strong, L., Towe, C. A., & McKenzie, M. (1999). Obstacles to needle exchange participation in Rhode Island. Journal of Acquired Immune Deficiency Syndrome, 21, 396–400.
   PubMed Web of Science ®Google Scholar
• Robles, R. R., Matos, T. D., Colon, H. M., Marrero, C. A., & Reyes, J. C. (1996). Effects of HIV testing and counseling on reducing HIV risk behavior among two ethnic groups. Drugs and Society, 9, 173–184.
   PubMedGoogle Scholar
• Robles, R. R., Reyes, J. C., Colon, H. M., Sahai, H., Marrero, C. A., Matos, T. D., (2004). Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico. Journal of Substance Abuse Treatment, 27(2), 145–152.
   PubMed Web of Science ®Google Scholar
• Sampson, R. J., & Wilson, W. J. (1995). Toward a theory of race, crime and urban inequality. In J. Hagan & R. D. Petersen (Eds.), Crime and inequality (pp. 37–54). Stanford, CA: Stanford University Press.
   Google Scholar
• Schilling, R. F., Fernando, D., Fontdevila, J., & El-Bassel, N. (2000). HIV risk reduction among injection drug users: Explaining the lack of anticipated outcomes in a community-level controlled comparison study. Evaluation and Program Planning, 23, 301–313.
   Web of Science ®Google Scholar
• Sinclair, M., Bor, R., Evans, A., Glass, D., Levitt, D., & Johnson, M. A. (2004). The sociodemographic profile, risk categories and prevalence of HIV infection among people attending a London same-day testing clinic, 2000–2001. International Journal of STDs and AIDS, 15, 33–37.
   PubMed Web of Science ®Google Scholar
• Solomon, L., Frank, R., Vlahov, D., & Astemborski, J. (1991). Utilization of health services in a cohort of injection drug users with known HIV-1 serostatus. American Journal of Public Health, 81, 1285–1290.
   PubMed Web of Science ®Google Scholar
• Stein, M. D., Piette, J., Mor, V., Wachtel, T. J., Fleishman, J., Mayer, K. H., (1991). Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. Journal of General Internal Medicine, 6, 35–40.
   PubMed Web of Science ®Google Scholar
• Sterk, C. E., Theall, K. P., Elifson, K. W., & Kidder, D. (2003). HIV risk reduction among African-American women who inject drugs: A randomized controlled trial. AIDS and Behavior, 7(1), 73–86.
   PubMed Web of Science ®Google Scholar
• Strathdee, S. (2006). Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug and Alcohol Dependence, 83(3), 225–232.
   PubMed Web of Science ®Google Scholar
• Strathdee, S. A., Palepu, A., Cornelisse, P. G., Yip, B., O'Shghnessy, M. V., Montaner, J. S., (1998). Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 547–549.
   PubMed Web of Science ®Google Scholar
• Sumartojo, E. (2000). Structural factors in HIV prevention: Concepts, examples, and implications for research. AIDS, (Suppl. 1), S3–S10.
   PubMed Web of Science ®Google Scholar
• Turner, B. J., Markson, L. E., McKee, L. J., Houchens, R., & Fanning, T. (1994a). Health care delivery, zidovudine use, and survival of women and men with AIDS. Journal of Acquired Immune Deficiency Syndrome, 7, 1250–1262.
   PubMed Web of Science ®Google Scholar
• Turner, B. J., McKee, L., Fanning, T., & Markson, L. E. (1994b). AIDS specialist versus generalist ambulatory care for advanced HIV infection and impact on hospital use. Medical Care, 32, 902–916.
   PubMed Web of Science ®Google Scholar
• Valleroy, L. A., Weinstein, B., Jones, T. S., Groseclose, S. L., Rolfs, R. T., & Kassler, W. J. (1995). Impact of increased legal access to needles and syringes on community pharmacies’ needle and syringe sales—Connecticut, 1992–1993. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 10, 73–81.
   PubMedGoogle Scholar
• Vlahov, D., & Junge, B. (1998). The role of needle exchange programs in HIV prevention. Public Health Reports, 113(Suppl. 1), 75–80.
   PubMedGoogle Scholar
• Watters, J. K., Estilo, M. J., Clark, G. L., & Lorvick, J. (1994). Syringe and needle exchange as HIV/AIDS prevention for injection drug users. Journal of the American Medical Association, 271, 115–120.
   PubMed Web of Science ®Google Scholar
• Weeks, M. R., Li, J., Dickson-Gomez, J., Convey, M., Martinez, M., Radda, K., (2009). Outcomes of a peer HIV prevention program with injection drug and crack users: The risk avoidance partnership. Substance Use and Misuse, 44(2), 253–281.
   PubMed Web of Science ®Google Scholar